US 10450382
Anti-complement C1s antibodies
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10450382 (Anti-complement C1s antibodies) held by Bioverativ USA Inc. expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bioverativ USA Inc.
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K49/00